Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers

Angelika Mühlebner, Jackelien van Scheppingen, Andrew de Neef, Anika Bongaarts, Till S. Zimmer, James D. Mills, Floor E. Jansen, Wim G.m. Spliet, Pavel Kršek, Josef Zámečnı́k, Roland Coras, Ingmar Blümcke, Martha Feucht, Theresa O. Scholl, Victoria‐Elisabeth Gruber, Johannes A. Hainfellner, Figen Söylemezoğlu, Katarzyna Kotulska, Lieven Lagae, Anna Jansen, David J. Kwiatkowski, Sergiusz Jóźwiak, Paolo Curatolo, Eleonora AronicaJournal of Neuropathology & Experimental Neurology 2020 · DOI

TL;DR

This study reveals that myelin pathology in Tuberous Sclerosis Complex (TSC) cortical tubers extends beyond the white matter into the gray matter, with reduced oligodendrocytes and myelin content. These findings correlate with cognitive dysfunction and autism spectrum disorder in TSC patients, suggesting a broader impact of TSC on brain development and function than previously understood.

What Problem Does This Paper Address?

Tuberous Sclerosis Complex (TSC) is a genetic disorder characterized by the formation of benign tumors (tubers) in various organs, including the brain. These cortical tubers are a major cause of treatment-resistant epilepsy, often necessitating surgical intervention. While white matter abnormalities like myelin loss and reduced oligodendrocytes have been observed in a subset of resected TSC tubers, the underlying mechanisms and the extent of this pathology, particularly within the gray matter, remained unclear. This paper aims to bridge this knowledge gap by investigating myelin pathology in both gray and white matter of TSC cortical tubers and its correlation with clinical manifestations, specifically cognitive function and neuropsychiatric comorbidities.

Methods

The researchers employed a comprehensive neuropathological and immunohistochemical analysis of resected cortical tubers from 46 TSC patients, along with control and perituberal tissue samples. A key methodological innovation was the use of semi-automated quantitative image analysis to assess the density of various cellular markers and myelin proteins. This approach allowed for precise quantification of:

  • Oligodendrocytes: Identified by the marker olig2.
  • Myelin: Assessed using myelin basic protein (MBP) and myelin-associated oligodendrocyte basic protein (MOBP).
  • Neurons: Marked by NeuN.
  • Astrogliosis: Detected by GFAP.
  • Inflammatory markers: Including CD3 (T-cells) and Cr3/43 (microglia).
  • Axonal integrity: Evaluated using phosphorylated neurofilament (SMI31).
  • Nodes of Ranvier: Assessed with CASPR immunofluorescence.

The study also incorporated clinical data from the patients, including cognitive assessments (IQ), epilepsy characteristics, and the presence of autism spectrum disorder (ASD) or TSC-associated neuropsychiatric disorder (TAND). Statistical analyses, including Kruskal-Wallis tests, Mann-Whitney-U tests, Kendall-tau correlations, and Chi-squared tests, were used to correlate neuropathological findings with clinical outcomes.

Datasets

The study utilized a dataset of 46 resected cortical tubers from TSC patients. This was supplemented with control samples, including 9 perituberal tissues from TSC patients and 34 autopsy cases and 5 surgical samples from individuals without neurological diseases. The clinical data was collected retrospectively from participating centers. No new datasets or benchmarks were introduced in this paper.

Key Insights and Ideas

  • Myelin pathology is not confined to white matter: A significant finding is the presence of myelin and oligodendrocyte abnormalities not only in the white matter but also within the gray matter of TSC cortical tubers. This challenges the previous understanding that TSC-related myelin issues were primarily a white matter phenomenon.
  • Oligodendrocyte reduction is widespread: The study observed a significant reduction in oligodendrocytes in both gray and white matter across all tuber types, suggesting a fundamental issue with myelin-producing cells in TSC.
  • Myelin loss is primarily in white matter: While oligodendrocytes were reduced in both gray and white matter, the actual myelin content (MBP) was significantly reduced specifically in the white matter of the tubers.
  • Inflammation may play a role: The presence of T-cells (CD3) in the gray and white matter was negatively correlated with both oligodendrocyte numbers and myelin content, hinting at an inflammatory component contributing to myelin pathology.
  • Cognitive deficits are linked to myelin integrity: Crucially, the number of oligodendrocytes in the white matter was significantly associated with the patients' IQ scores, and the amount of MOBP in the gray matter was linked to the presence of autism spectrum disorder. This provides a direct link between myelin pathology and neuropsychiatric comorbidities in TSC.
  • Axons remain intact, but myelin sheaths are compromised: The study found no difference in axonal density (SMI31) but observed a reduction in the integrity of myelin sheaths at the nodes of Ranvier (CASPR) at the gray-white matter border, suggesting a problem with myelin formation or maintenance rather than axonal loss.

Key Results

  • Oligodendrocytes: Reduced in both gray (p=0.002) and white matter (p=0.001) across all tuber types compared to controls.
  • Myelin (MBP): Significantly reduced in the white matter of all tuber types (p<0.001) compared to controls and perituberal samples.
  • T-cells (CD3): Increased in both gray and white matter of tubers, with a significant association between CD3-positive T-cells and reduced oligodendroglia and MBP.
  • Cognitive Function: A significant association was found between lower numbers of oligodendroglia in the white matter and lower IQ scores (p=0.023).
  • Autism Spectrum Disorder (ASD): The presence of ASD was significantly associated with the amount of MOBP in the gray matter (p=0.007).
  • Nodes of Ranvier: A reduction in CASPR positivity was observed at the gray-white matter border in type B and C tubers (p=0.016).

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Data Collection: Clinical data, particularly neuropsychological assessments, were collected retrospectively and across different countries, which may introduce variability.
  • Tissue-Based Analysis: The study provides a snapshot of the brain at the time of surgery, and the dynamic nature of myelin pathology and its development over time is not fully captured.
  • Focus on TSC: The study specifically focused on TSC to control for genetic background. Future work could explore whether these findings generalize to other epilepsy-associated pathologies.

Promising future directions suggested by the authors include:

  • Investigating the role of the immune system: Further research is needed to elucidate the precise role of T-cells and other inflammatory components in TSC-related myelin pathology, potentially using experimental models.
  • Exploring gray matter myelination: Given the emerging understanding of gray matter myelination and its plasticity, further investigation into its role in TSC and other mTORopathies is warranted.
  • Single-cell RNA-Seq analyses: These could be valuable for identifying specific alterations in oligodendrocyte heterogeneity in TSC, potentially revealing new therapeutic targets.
  • Understanding the mTOR pathway's role: Continued research into how mTOR dysregulation impacts oligodendrocyte differentiation and myelin formation is crucial.

Summary updated

Abstract

Tuberous sclerosis complex (TSC) is a monogenetic disease that arises due to mutations in either the TSC1 or TSC2 gene and affects multiple organ systems. One of the hallmark manifestations of TSC are cortical malformations referred to as cortical tubers. These tubers are frequently associated with treatment-resistant epilepsy. Some of these patients are candidates for epilepsy surgery. White matter abnormalities, such as loss of myelin and oligodendroglia, have been described in a small subset of resected tubers but mechanisms underlying this phenomenon are unclear. Herein, we analyzed a variety of neuropathologic and immunohistochemical features in gray and white matter areas of resected cortical tubers from 46 TSC patients using semi-automated quantitative image analysis. We observed divergent amounts of myelin basic protein as well as numbers of oligodendroglia in both gray and white matter when compared with matched controls. Analyses of clinical data indicated that reduced numbers of oligodendroglia were associated with lower numbers on the intelligence quotient scale and that lower amounts of myelin-associated oligodendrocyte basic protein were associated with the presence of autism-spectrum disorder. In conclusion, myelin pathology in cortical tubers extends beyond the white matter and may be linked to cognitive dysfunction in TSC patients.
BibTeX
@article{muhlebner2020myelin,
  author = {Angelika Mühlebner and Jackelien van Scheppingen and Andrew de Neef and Anika Bongaarts and Till S. Zimmer and James D. Mills and Floor E. Jansen and Wim G.M. Spliet and Pavel Kršek and Josef Zámečnı́k and Roland Coras and Ingmar Blümcke and Martha Feucht and Theresa O. Scholl and Victoria‐Elisabeth Gruber and Johannes A. Hainfellner and Figen Söylemezoğlu and Katarzyna Kotulska and Lieven Lagae and Anna Jansen and David J. Kwiatkowski and Sergiusz Jóźwiak and Paolo Curatolo and Eleonora Aronica},
  title = {{Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers}},
  journal = {Journal of Neuropathology \& Experimental Neurology},
  year = {2020},
  doi = {10.1093/jnen/nlaa090},
}
Figure